MurrayBGordonMD
Endocrinology • Pittsburgh, PADiabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology, Thyroid
Physician
Dr. Gordon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
420 E North Ave
Suite 205
Pittsburgh, PA 15212Phone+1 412-359-3426Fax+1 412-359-6974
Education & Training
Brigham and Women's HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1980 - 1982
UPMC Medical EducationResidency, Internal Medicine, 1977 - 1980
Albany Medical CollegeClass of 1977
Certifications & Licensure
PA State Medical License 1978 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. Start of enrollment: 2011 Aug 16
- An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
- Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease Start of enrollment: 2013 Mar 28
- Join now to see all
Publications & Presentations
PubMed
- 51 citationsRevised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic–pituitary–adrenal axes in adults: results from a prospect...Amir H. Hamrahian, Kevin C.J. Yuen, Murray B. Gordon, Karen J. Pulaski-Liebert, James Bena
Pituitary. 2016-02-20 - 19 citationsClinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations.David R. Brown, Honey E. East, Bradley S. Eilerman, Murray B. Gordon, Elizabeth E. King
Clinical Diabetes and Endocrinology. 2020-10-29 - 27 citationsRelacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Ph...Rosario Pivonello, Irina Bancos, Richard A Feelders, Atil Y. Kargi, Janice M. Kerr
Frontiers in Endocrinology. 2021-07-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
